In their study, 18 (81.8%) patients had multiple leiomyomas (ranging from 2 to 14 cm) and 0.4% of uterine leiomyomas were proved to be FH-deficient, while none presented as leiomyosarcoma. The gene discussed is FH; the disease is uterine corpus leiomyoma.